A Placebo-Controlled, Double-Blind, Randomized, Parallel-Group Study Of The Efficacy And Safety Of Dapoxetine In The Treatment Of Subjects With Premature Ejaculation.
Phase of Trial: Phase III
Latest Information Update: 23 Oct 2016
At a glance
- Drugs Dapoxetine (Primary)
- Indications Premature ejaculation
- Focus Registrational; Therapeutic Use
- Sponsors Janssen Research & Development
- 08 Apr 2009 Actual end date (Oct 2006) added as reported by ClinicalTrials.gov.
- 08 Apr 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Dec 2005 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History